Work

Effects of nintedanib in patients with progressive fibrosing interstitial lung disease associated with rheumatoid arthritis (RA-ILD) in the INBUILD trial*

Year: 2022

Type: article

Source: Pneumologie

DOI: 10.1055/s-0042-1747733

Authors: D Koschel, C Kelly, E Matteson, M Aringer, G Burmester, H Mueller, L Moros, K B Rohr, M Kolb

Institutions: Newcastle University, Mayo Clinic, Technische Universität Dresden, Stiftung Charité, Charité – Universitätsmedizin Berlin, Boehringer Ingelheim (Germany), St. Joseph’s Healthcare Hamilton, McMaster University

Language: English

Topic: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4293147698

FWCI:

Cites:

Cited by:

Related to: 10